US equities
|
NVDA
$236.39
▲+1.04%
MU
$1,065.65
▼-0.86%
INTC
$116.03
▼-2.77%
MSFT
$526.49
▲+1.73%
AMD
$626.87
▼-1.11%
SPCX
$160.41
▲+0.92%
TSLA
$365.27
▼-1.44%
META
$732.77
▲+0.64%
NVDA
$236.39
▲+1.04%
MU
$1,065.65
▼-0.86%
INTC
$116.03
▼-2.77%
MSFT
$526.49
▲+1.73%
AMD
$626.87
▼-1.11%
SPCX
$160.41
▲+0.92%
TSLA
$365.27
▼-1.44%
META
$732.77
▲+0.64%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Bial
Bial Showcases Parkinson’s Research at MDS 2026
Today 2:00 EDT
From
Bial
Via
Business Wire
Bial Reports Topline Results From ACTIVATE Phase 2b Study in GBA‑Associated Parkinson’s
June 09, 2026
From
Bial
Via
Business Wire
Bial Announces Completion of Phase 2b ACTIVATE Study with BIA 28-6156 in GBA1-Associated Parkinson’s
May 26, 2026
From
Bial
Via
Business Wire
Bial Achieves Key Milestone in Phase 2b ACTIVATE Study of BIA 28-6156 in GBA1-Associated Parkinson’s Disease
January 27, 2026
From
Bial
Via
Business Wire
Key Milestone in ACTIVATE Phase 2 Clinical Trial of BIA 28-6156
October 02, 2025
From
Bial
Via
Business Wire